{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-243481","form_type":"8-K","ticker":"ENGN","cik":"0001980845","company_name":"enGene Therapeutics Inc.","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.515950+00:00","generated_at":"2026-05-30T10:10:22.659432+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"enGene raises $60M via private placement of 6.76M shares at $8.90/share","bullets":["Gross proceeds ~$60M from sale of 6,758,311 common shares at $8.90/share; expected close Oct 29, 2024.","Investors include Deep Track Capital, Cormorant Asset Management, Forbion, OrbiMed, Sphera Healthcare, Vestal Point Capital, Venrock Healthcare.","Net proceeds to fund detalimogene development, pre-commercial activities, DDX platform expansion, and working capital.","Combined with existing cash, expected to fund operating plan into 2027.","Leerink Partners, Piper Sandler, Guggenheim, Wells Fargo acted as placement agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-243481","json":"https://secwatch.observer/filing/0001193125-24-243481.json","markdown":"https://secwatch.observer/filing/0001193125-24-243481.md","text":"https://secwatch.observer/filing/0001193125-24-243481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1980845/000119312524243481/0001193125-24-243481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1980845/000119312524243481/d863566d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:10:22.659432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}